BioSpace News Archive

Press Releases

TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03

February 26, 2026
·
7 min read
Press Releases

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update

February 26, 2026
·
21 min read
Press Releases

Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

February 26, 2026
·
16 min read
Press Releases

Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results

February 26, 2026
·
23 min read
Press Releases

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

February 26, 2026
·
18 min read
Press Releases

AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder

February 26, 2026
·
10 min read
Press Releases

Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

February 26, 2026
·
12 min read
Press Releases

Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026

February 26, 2026
·
6 min read
Press Releases

Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership

February 26, 2026
·
5 min read
Press Releases

Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026

February 26, 2026
·
3 min read